Worth reading
51Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
200
Units (up to 20,000 shares)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as stock options
発行・処分する株式数
200 share acquisition rights (maximum), 100 shares per right, for a total of 20,000 shares (maximum)
Intended allottee
Category Directors of the company / Number of Employees 7 / Allocation limit 60, Category Our Audit & Supervisory Board member / Number of Employees 3 / Number of allocated shares Not disclosed, Category The Company's employees / Number of Employees 85 / Number of allocated shares Not disclosed
At no cost (no monetary payment required)
Amount of funds to be raised
Total amount to be paid: Not disclosed; estimated net proceeds: Not disclosed
Terms of the stock acquisition rights
Exercise price
The exercise price per share will be determined using the calculation method above. Adjustment provisions apply in connection with share splits, reverse share splits, and the issuance of new shares or disposal of treasury shares at a price below market value. The adjustment floor is Not disclosed.
Exercise period
Start Date 25 August 2028 / End date 6 August 2036
Number of Stock Acquisition Rights
Total number issued: 200 rights (maximum), remaining unexercised: Not disclosed
Reason for acquisition without consideration
If a holder of the share acquisition rights loses their position as a director, audit & supervisory board member or employee, waives all or part of the rights, or a merger agreement or other similar agreement under which the Company would cease to exist as the surviving company is approved at a general meeting of shareholders.
Categories and Number of Persons Covered
7 of the Company's directors, 3 of the Company's audit & supervisory board members and 85 of the Company's employees. The breakdown of the number of shares allocated by category is Not disclosed.
Intended allottee's holding policy
Transfers of the share acquisition rights require approval by the Board of Directors.
Payment date
Not applicable (issued at no cost)
Basis for determining the amount to be paid
The exercise price will be calculated by multiplying the average closing price for regular trading on the Tokyo Stock Exchange on each trading day during the month preceding the month in which the share acquisition rights are issued by 1.05. However, if this amount is below the closing price on the issue date, the closing price on the issue date will apply.
Procedures under the Corporate Code of Conduct
Pursuant to the authority delegated by the annual general meeting of shareholders held on 24 July 2026, the Board of Directors decided the offering terms at its meeting held on 7 August 2026. Acquisition of an opinion from an independent third party: Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as stock options |
| Number of shares to be issued or disposed of | 200 share acquisition rights (maximum), 100 shares per right, for a total of 20,000 shares (maximum) |
| Issue price and disposal price | At no cost (no monetary payment required) |
| Amount of funds to be raised | Total amount to be paid: Not disclosed; estimated net proceeds: Not disclosed |
| Payment date | Not applicable (issued at no cost) |
| Intended allottee | Category Directors of the company / Number of Employees 7 / Allocation limit 60, Category Our Audit & Supervisory Board member / Number of Employees 3 / Number of allocated shares Not disclosed, Category The Company's employees / Number of Employees 85 / Number of allocated shares Not disclosed |
| Intended allottee's holding policy | Transfers of the share acquisition rights require approval by the Board of Directors. |
| Basis for determining the amount to be paid | The exercise price will be calculated by multiplying the average closing price for regular trading on the Tokyo Stock Exchange on each trading day during the month preceding the month in which the share acquisition rights are issued by 1.05. However, if this amount is below the closing price on the issue date, the closing price on the issue date will apply. |
| Exercise price | The exercise price per share will be determined using the calculation method above. Adjustment provisions apply in connection with share splits, reverse share splits, and the issuance of new shares or disposal of treasury shares at a price below market value. The adjustment floor is Not disclosed. |
| Exercise period | Start Date 25 August 2028 / End date 6 August 2036 |
| Number of Stock Acquisition Rights | Total number issued: 200 rights (maximum), remaining unexercised: Not disclosed |
| Reason for acquisition without consideration | If a holder of the share acquisition rights loses their position as a director, audit & supervisory board member or employee, waives all or part of the rights, or a merger agreement or other similar agreement under which the Company would cease to exist as the surviving company is approved at a general meeting of shareholders. |
| Categories and Number of Persons Covered | 7 of the Company's directors, 3 of the Company's audit & supervisory board members and 85 of the Company's employees. The breakdown of the number of shares allocated by category is Not disclosed. |
| Procedures under the Corporate Code of Conduct | Pursuant to the authority delegated by the annual general meeting of shareholders held on 24 July 2026, the Board of Directors decided the offering terms at its meeting held on 7 August 2026. Acquisition of an opinion from an independent third party: Not disclosed. |
Items this document does not state (14)
Total issue valueEstimated issuance expensesSpecific use of fundsDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The purpose is to enhance motivation and morale to contribute to the long-term enhancement of the Company's corporate value, among other objectives.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.